Vargatef

News

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.

News

Using Claude Science, Claude agents designed high-affinity protein binders for a range of targets, outperforming human experts in some cases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.